Opko Health Profile



Odds of Distress

Check how we calculate scores
Equity ratings for Opko Health are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting July 22, 2019 and ending today October 20, 2019. Click here to learn more.
Earning Report: November 8, 2019   Follow

Opko Health Profile

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida. Opko Health operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 5690 people. more
Opko Health Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Opko Health SEC Filings
Opko Health SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameOpko Health
Chairman of the Board, CEOPhilip FrostView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Drug Manufacturers - Specialty & Generic
InstrumentUSA Stock View All
RegionNorth America
LocationFlorida U.S.A
Business Address4400 Biscayne Boulevard
Foreign Associate  Israel
ExchangeBATS Exchange
CIK Number0000944809
IndustryDrug Manufacturers - Specialty & Generic
Phone305 575 4100
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestSeptember 30, 2019
Opko Health (OPK) is traded on BATS Exchange in USA. It is located in 4400 Biscayne Boulevard and employs 5,690 people. Opko Health is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with total capitalization of 1.26 B. Opko Health runs under Healthcare sector within Drug Manufacturers - Specialty & Generic industry. The entity has 615.6 M outstanding shares of which 85.98 M shares are now shorted by investors with about 26.01 days to cover shorted positions. OPKO HEALTH INC. has about 111.11 M in cash with (59.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18.
Check Opko Health Probability Of Bankruptcy

Ownership Allocation (%)

Opko Health Target Price Odds Analysis

Odds Below 2.17HorizonTargetOdds Above 2.17
90.16%30 days 2.17 9.74%
Based on normal probability distribution, the odds of Opko Health to move above current price in 30 days from now is about 9.74 (This Opko Health probability density function shows the probability of Opko Health Stock to fall within a particular range of prices over 30 days) .

Opko Health Top Holders

Opko Health Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Opko Health Key Fundamentals

Opko Health Against Markets

Did you try this?

Run Efficient Frontier Now


Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Opko Health Upcoming and Recent Events

Opko Health Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportNovember 8, 2019
Next Earnings ReportFebruary 26, 2020
Next Fiscal Quarter EndSeptember 30, 2019
Next Fiscal Year EndFebruary 26, 2020
Last Quarter Report DateJune 30, 2019
Last Earning Anouncement DateSeptember 30, 2018

Opko Health Corporate Filings

Opko Health SEC Reporting

Unclassified Corporate Event
Financial Statements and Exhibits. Regulation FD Disclosure
Other Events. Regulation FD Disclosure. Unclassified Corporate Event
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Opko Health Corporate Directors

Robert Fishel Independent Director
Robert Baron Independent Director
Alice Yu Independent Director
Additionally take a look at Your Equity Center. Please also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Search macroaxis.com